Vitamin C for eye cell protection during cataract surgery
Part of Blood & lymphatic, Cancer, Eyes & vision, Immune system & allergy clinical trials.
This trial tests whether taking vitamin C before and after cataract surgery can help protect the inner layer of the eye. It is for people aged 60 or older with hard, age-related cataracts who are having phacoemulsification surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older
- You have a hard cataract (not yet fully mature) in one or both eyes
- You are willing to have cataract surgery and take vitamin C for 7 weeks
- You have not had eye surgery before
- You are not allergic to vitamin C
- You do not take other vitamins regularly
- You agree to join the study and sign the consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests how safe and tolerable an investigational treatment (EO2002) is in adults having cataract surgery. It also looks at whether the treatment can be given without causing harmful effects in people with reduced cornea cell counts.
This trial tests an eye drop called CA201A to see if it can prevent loss of cells in the clear front layer of the eye (the cornea) after cataract surgery. The drop contains ascorbic acid, a form of vitamin C, and is given before and after the procedure to help protect the eyesight.
This trial looks at antioxidant levels and stress in people having either corneal refractive surgery or cataract surgery. If you are having one of these eye surgeries and do not have an eye infection, severe retinal disease, or a serious eye injury, you may be eligible to join.
This study tests a new anti-inflammatory eye drop (PRO-232) in people who had routine cataract surgery on one eye the day before. The goal is to see if it helps control swelling and pain without problems.
This Phase 2 study tests whether eye drops containing a medicine called N-acetylcysteine (NAC) can reduce damaging “reactive oxygen” in people with advanced Fuchs’ endothelial corneal dystrophy (FECD). It involves people who need a special cornea transplant (DMEK) at the same time as cataract surgery, aiming to improve cornea healing and vision.
This study examines how different surgical approaches during cataract removal affect your vision and eye health after surgery. If you need cataract surgery, this trial may help doctors understand which techniques work best for patients like you.
Hear when a new Endothelial Cell Loss, Corneal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.